57
Participants
Start Date
November 18, 2020
Primary Completion Date
September 5, 2022
Study Completion Date
September 6, 2022
Gadoquatrane (BAY1747846)
Solution for IV injection, single dose
Gadobutrol (Gadovist/Gadavist)
Solution for IV injection, single dose
Acibadem City Clinic Multiprofile Hospital for Active Treatm, Sofia
University Multiprofile Hosp. for Active Treat. Sveti Ivan, Sofia
UMHAT Sveti Georgi, Plovdiv
Penn State Milton S. Hershey Medical Center, Hershey
MVZ Prof. Uhlenbrock und Partner, Dortmund
Universitätsklinikum Essen, Essen
Northwestern University, Chicago
University of Iowa Hospitals & Clinics, Iowa City
Friedrich-Schiller-Uni. Jena, Jena
Hokkaido University Hospital, Sapporo
National Hospital Organization Himeji Medical Center, Himeji
Hyogo Prefectural Nishinomiya Hospital, Nishinomiya
Kishiwada Tokushukai Hospital, Kishiwada
National Hospital Organization Kanmon Medical Center, Shimonoseki
National Hospital Organization Kyushu Medical Center, Fukuoka
Social Medical Corporation the Chiyukai foundation Fukuoka Wajiro Hospital, Fukuoka
Hiroshima City Hiroshima Citizens Hospital, Hiroshima
Lead Sponsor
Bayer
INDUSTRY